BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

863 related articles for article (PubMed ID: 16096168)

  • 1. Testosterone in older men after the Institute of Medicine Report: where do we go from here?
    Harman SM
    Climacteric; 2005 Jun; 8(2):124-35. PubMed ID: 16096168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Should older men be treated with testosterone?].
    Svartberg J
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):879-82. PubMed ID: 15815734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
    Blümel JE; Chedraui P; Gili SA; Navarro A; Valenzuela K; Vallejo S
    Maturitas; 2009 Aug; 63(4):365-8. PubMed ID: 19481382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and the ageing male.
    Swerdloff RS; Wang C
    Best Pract Res Clin Endocrinol Metab; 2004 Sep; 18(3):349-62. PubMed ID: 15261842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
    Miner MM; Seftel AD
    Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining 'relative' androgen deficiency in aging men: how should testosterone be measured and what are the relationships between androgen levels and physical, sexual and emotional health?
    Haren MT; Morley JE; Chapman IM; O'Loughlin PD; Wittert GA
    Climacteric; 2002 Mar; 5(1):15-25. PubMed ID: 11974555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB; Rajfer J
    Urol Clin North Am; 2012 Feb; 39(1):63-75. PubMed ID: 22118346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining testicular function in aging men.
    Tenover JS
    Int J Impot Res; 2003 Aug; 15 Suppl 4():S3-8. PubMed ID: 12934044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Androgen deficiency in older men--what happens with testosterone substitution?].
    Jockenhövel F
    Dtsch Med Wochenschr; 2001 Mar; 126(9):247-52. PubMed ID: 11256040
    [No Abstract]   [Full Text] [Related]  

  • 13. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
    Swerdloff RS; Wang C
    Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Testosterone substitution in patients with hypogonadism].
    Martínez Portillo FJ; Cueva Martínez A; Martin Braun P; Fernández Arancibia MI; Jünemann KP; Alken P
    Arch Esp Urol; 2002 Sep; 55(7):827-38. PubMed ID: 12380312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone and the aging male.
    Tenover JL
    J Androl; 1997; 18(2):103-6. PubMed ID: 9154502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in the treatment of testosterone deficiency syndrome.
    Hong BS; Ahn TY
    Int J Urol; 2007 Nov; 14(11):981-5. PubMed ID: 17956520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone correlated to symptoms of partial androgen deficiency in aging men (PADAM) in an elderly Swedish population.
    Spetz AC; Palmefors L; Skobe RS; Strömstedt MT; Fredriksson MG; Theodorsson E; Hammar ML
    Menopause; 2007; 14(6):999-1005. PubMed ID: 17529900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of androgen supplementation therapy on the prostate.
    Kaufman JM
    Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.